Gougos A, St Jacques S, Greaves A, O'Connell P J, d'Apice A J, Bühring H J, Bernabeu C, van Mourik J A, Letarte M
Division of Immunology and Cancer Research, Hospital for Sick Children, Toronto, Canada.
Int Immunol. 1992 Jan;4(1):83-92. doi: 10.1093/intimm/4.1.83.
Endoglin is a glycoprotein expressed predominantly on human endothelial cells. It was first identified with mAb 44G4, produced against the pre-B acute lymphoblastic HOON cell line. We now report that four mAbs independently produced against human umbilical vein endothelial cells (HUVECs), chronic myelogenous leukemia in blast crisis, or U-937 pro-monocytic cells stimulated with phorbol myristate acetate also react with endoglin. High levels of reactivity of all mAbs were observed with HUVEC, while intermediate levels were seen with HOON and U-937 cells. By sequential immunoprecipitation from HUVEC and U-937 cell extracts, it was established that RMAC8, HEC-19, 8E11, and 1G2 mAbs react with the same protein as 44G4. Three distinct epitopes recognized by 44G4, RMAC8, and 1G2 mAbs were identified by competitive radioimmunoassay and flow cytometry. The HEC-19 epitope is spatially related to the 44G4 epitope, whereas the 8E11 epitope is most closely related to the 1G2 epitope. Western blot analysis showed that all antibodies react with the endoglin dimer (Mr = 170,000) purified from placenta. Immunostaining of sections of full-term placenta revealed reactivity not only with fetal vessels but also with the syncytiotrophoblast, the fetal cell layer which interfaces with maternal blood. When HUVEC monolayers were treated with the different mAbs to endoglin, prior to incubation with U-937 cells, a 5- to 10-fold stimulation of adhesion was observed. A fibronectin hexapeptide containing RGD, but not the corresponding RGE peptide, was capable of inhibiting the increased adhesion, when tested with mAb 44G4 and RMAC8. However, the same peptides had no effect on the binding of any of the five anti-endoglin mAbs to cells. Since 44G4 and RMAC8 recognize two distinct epitopes of endoglin, and since all five mAbs stimulated adhesion, the results suggest that a signal has been triggered through endoglin on HUVECs. Endoglin might be implicated either directly, by binding to a specific integrin-like ligand, or indirectly, by regulating the level of adhesion between certain integrins and their receptors.
内皮糖蛋白是一种主要在人内皮细胞上表达的糖蛋白。它最初是用针对前B急性淋巴细胞白血病HOON细胞系产生的单克隆抗体44G4鉴定出来的。我们现在报告,针对人脐静脉内皮细胞(HUVECs)、急变期慢性粒细胞白血病或用佛波醇肉豆蔻酸酯乙酸盐刺激的U - 937原单核细胞独立产生的四种单克隆抗体也与内皮糖蛋白发生反应。所有单克隆抗体与HUVECs反应性高,而与HOON和U - 937细胞反应性中等。通过从HUVECs和U - 937细胞提取物中进行连续免疫沉淀,确定RMAC8、HEC - 19、8E11和1G2单克隆抗体与44G4反应的是同一种蛋白质。通过竞争性放射免疫测定和流式细胞术鉴定了44G4、RMAC8和1G2单克隆抗体识别的三个不同表位。HEC - 19表位在空间上与44G4表位相关,而8E11表位与1G2表位关系最密切。蛋白质免疫印迹分析表明,所有抗体都与从胎盘中纯化的内皮糖蛋白二聚体(Mr = 170,000)发生反应。足月胎盘切片的免疫染色显示,不仅与胎儿血管有反应,而且与合体滋养层有反应,合体滋养层是与母体血液接触的胎儿细胞层。当在与U - 937细胞孵育之前,用不同的内皮糖蛋白单克隆抗体处理HUVEC单层时,观察到粘附增加了5至10倍。当用单克隆抗体44G4和RMAC8测试时,含RGD的纤连蛋白六肽而非相应的RGE肽能够抑制增加的粘附。然而,相同的肽对五种抗内皮糖蛋白单克隆抗体中任何一种与细胞的结合没有影响。由于44G4和RMAC8识别内皮糖蛋白的两个不同表位,并且由于所有五种单克隆抗体都刺激了粘附,结果表明通过HUVECs上的内皮糖蛋白触发了一个信号。内皮糖蛋白可能直接通过与特定的整合素样配体结合起作用,或者间接通过调节某些整合素与其受体之间的粘附水平起作用。